The Ozempic shortage is over

The shortage of Novo Nordisk’s (NVO) blockbuster diabetes and weight-loss drugs is officially over, according to the U.S. Food and Drug Administration (FDA).Read more…

The shortage of Novo Nordisk’s (NVO) blockbuster diabetes and weight-loss drugs is officially over, according to the U.S. Food and Drug Administration (FDA).Read more…
Read More

About Author

Bruce Gil

See author's posts

The Ozempic shortage is over

About Author

Bruce Gil

FDA steps up import enforcement for pesticides, Salmonella and more import

Vaccine shows promise for pancreatic cancer, study finds

Miami attorney on tap to lead FDA foods program, including food safety efforts

FDA steps up import enforcement for pesticides, Salmonella and more import

Vaccine shows promise for pancreatic cancer, study finds

Miami attorney on tap to lead FDA foods program, including food safety efforts

FDA Approves First Drug for Rare Lipid Storage Disorder

Mack Weldon Airknitx Boxer Brief Review: A Game-Changer for Your Top Drawer

Coffee, Tea Tied to Lower Risk of Head and Neck Cancer

Doc Suspected in Mass Killing; Vaccine Injury Claims Spike; Iowa Has First H5N1 Case

2024 Was the Year of the Threesome in Film and TV

Navigating the Blood Cancer Journey: What Everyone Should Know

Alzheimer’s progression tied to stress-induced microglial lipid release

FDA steps up import enforcement for pesticides, Salmonella and more import

Vaccine shows promise for pancreatic cancer, study finds

Miami attorney on tap to lead FDA foods program, including food safety efforts

FDA Approves First Drug for Rare Lipid Storage Disorder

Mack Weldon Airknitx Boxer Brief Review: A Game-Changer for Your Top Drawer

About PhaMed

Recent News

About Author

More Stories

You may have missed

About PhaMed

Recent News

Categories